tiprankstipranks
Eli Lilly & Co (LLY)
NYSE:LLY

Eli Lilly & Co Stock Forecast & Price Targets

3,549 Followers
See the Price Targets and Ratings of:

Analyst Rating Consensus

Strong Buy
10Ratings
10 Buy
0 Hold
0 Sell
Based on 10 analysts giving stock ratings to
Eli
Lilly & Co
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

Analyst Price Target on LLY

Average Price Target

$354.90
▲(12.02% Upside)
Based on 10 Wall Street analysts offering 12 month price targets for Eli Lilly & Co in the last 3 months. The average price target is $354.90 with a high forecast of $395.00 and a low forecast of $335.00. The average price target represents a 12.02% change from the last price of $316.82.
Highest Price Target$395.00Average Price Target$354.90Lowest Price Target$335.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Upgrade Banner
UBS
$293.00
Hold
-7.52%
Downside
Reiterated
Eli Lilly (LLY) PT Raised to $293 at UBSUBS analyst Navin Jacob raised the price target on Eli Lilly (NYSE: LLY) to $293.00 (from $267.00) while maintaining a Neutral rating.
Atlantic Equities
$260.00
Hold
-17.93%
Downside
Reiterated
Eli Lilly (LLY) PT Raised to $260 at Atlantic EquitiesAtlantic Equities analyst Steve Chesney raised the price target on Eli Lilly (NYSE: LLY) to $260.00 (from $230.00) while maintaining a Neutral rating.
Wells Fargo
$305.00
Hold
-3.73%
Downside
Reiterated
Eli Lilly price target raised to $305 from $280 at Wells FargoEli Lilly price target raised to $305 from $280 at Wells Fargo
Goldman Sachs
$264.00
Hold
-16.67%
Downside
Reiterated
Goldman Sachs Maintains Their Hold Rating on Eli Lilly & Co (LLY)
Bank of America Securities
$315.00
Buy
-0.57%
Downside
Reiterated
Eli Lilly (LLY) price target raised to $315 from $300 at BofA" His higher price target is based on updated forecasts for tirzepatide in obesity, Meacham noted.
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
PRVAPrivia Health Group
RXDXPrometheus Biosciences
ROIVRoivant Sciences
ABCLAbCellera Biologics
NRIXNurix Therapeutics
Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

FAQ

What is LLY’s average 12-month price target, according to analysts?
Based on analyst ratings, Eli Lilly & Co’s 12-month average price target is $354.90.
    What is LLY’s upside potential, based on the analysts’ average price target?
    Eli Lilly & Co has 12.02% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

          What's Included in PREMIUM?
          Make informed decisions based on Top Analysts' activity
          Know what industry insiders are buying
          Get actionable alerts from top Wall Street Analysts
          Find out before anyone else which stock is going to shoot up
          Get powerful stock screeners & detailed portfolio analysis